Prognostically Significant Fusion Oncogenes in Pakistani Patients with Adult Acute Lymphoblastic Leukemia and their Association with Disease Biology and Outcome

Sabir, Noreen; Iqbal, Zafar; Aleem, Aamer; Awan, Tashfeen; Naeem, Tahir; Asad, Sultan; Tahir, Ammara H; Absar, Muhammad; Hasanato, Rana MW; Basit, Sulman; Chishti, Muhammad Azhar; Ul-Haque, Muhammad Faiyaz; Khalid, Ahmad Muktar; Sabar, Muhammad Farooq; Rasool, Mahmood; Karim, Sajjad; Khan, Mahwish; Samreen, Baila; Akram, Afia M; Siddiqi, Muhammad Hassan; Shahzadi, Saba; Shahbaz, Sana; Ali, Agha Shabbir

추천

검색

자료유형: 학술저널

저자정보: Sabir, Noreen (Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Iqbal, Zafar (Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Aleem, Aamer (Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Awan, Tashfeen (Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Naeem, Tahir (Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Asad, Sultan (Centre for Advanced Molecular Biology, University of Lahore) Tahir, Ammara H (Hematology, Oncology and Pharmaco) Absar, Muhammad Hasanato, Rana MW Basit, Sulman Chishti, Muhammad Azhar Ul-Haque, Muhammad Faiyaz Khalid, Ahmad Muktar Sabar, Muhammad Farooq Rasool, Mahmood Karim, Sajjad Khan, Mahwish Samreen, Baila Akram, Afia M Siddiqi, Muhammad Hassan Shahzadi, Saba Shahbaz, Sana Ali, Agha Shabbir

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제7호

발행연도: 2012.1

수록면: 3,349 - 3,355 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background and objectives: Chromosomal abnormalities play an important role in genesis of acute lymphoblastic leukemia (ALL) and have prognostic implications. Five major risk stratifying fusion genes in ALL are BCR-ABL, MLL-AF4, ETV6-RUNX11, E2A-PBX1 and SIL-TAL1. This work aimed to detect common chromosomal translocations and associated fusion oncogenes in adult ALL patients and study their relationship with clinical features and treatment outcome. Methods: We studied fusion oncogenes in 104 adult ALL patients using RT-PCR and interphase-FISH at diagnosis and their association with clinical characteristics and treatment outcome. Results: Five most common fusion genes i.e. BCR-ABL (t 9; 22), TCF3-PBX1 (t 1; 19), ETV6-RUNX1 (t 12; 21), MLL-AF4 (t 4; 11) and SIL-TAL1 (Del 1p32) were found in 82/104 (79%) patients. TCF3-PBX1 fusion gene was associated with lymphadenopathy, SIL-TAL1 positive patients had frequent organomegaly and usually presented with a platelets count of less than $50{\times}10^9/l$. Survival of patients with fusion gene ETV6-RUNX1 was better when compared to patients harboring other genes. MLL-AF4 and BCR-ABL positivity characterized a subset of adult ALL patients with aggressive clinical behaviour and a poor outcome. Conclusions: This is the first study from Pakistan which investigated the frequency of5 fusion oncogenes in adult ALL patients, and their association with clinical features, treatment response and outcome. Frequencies of some of the oncogenes were different from those reported elsewhere and they appear to be associated with distinct clinical characteristics and treatment outcome. This information will help in the prognostic stratification and risk adapted management of adult ALL patients.

#Acute lymphoblastic leukemia #ALL #adult #fusion oncogenes #Pakistan

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Sabir, Noreen

소속기관 Hematology, Oncology and Pharmacogenetic Engineering Sciences Group, Health Sciences Laboratories, F